Supraciliary microstenting: advancing glaucoma treatment in the age of MIGS
July 1st 2015In this article, Dr Ianchulev discusses MIGS supraciliary microstenting, a compelling new approach for outflow enhancement that results in sustained reduction of IOP and anti-hypertensive topical medication use in OAG patients.
Tips to best manage exfoliative glaucoma
July 1st 2015Exfoliative glaucoma can prove to be a particularly difficult disease for opthalmologists to manage. In this article, aspects of IOP-lowering therapy specific to this type of glaucoma are considered, as well as the range of treatments available and the potential advantages and challenges associated with each therapy.
Aflibercept fares well in treating DME
June 24th 2015Intravitreal aflibercept 2 mg every 8 weeks after 5 initial monthly doses (IVT-AFL 2q8) improved visual acuity outcomes in eyes with center-involved diabetic macular edema (DME) to a greater extent than intravitreal ranibizumab 0.5 mg as needed (IVR 0.5 mg PRN), though vascular endothelial growth factor (VEGF) inhibition with either IVT-AFL or IVR is efficacious and appears safe
Combo therapy improves VA in AMD patients
June 23rd 2015Anti-vascular endothelial growth factor (anto-VEGF) monotherapy is inadequate in patients with age-related macular degeneration (AMD). However, by adding an anti-platelet-derived growth factor (anti-PDGF) drug to the anti-VEGF regimen, treatment is enhanced by preventing the development of fibrosis thus improving visual outcomes, according to Usha Chakravarthy, MBBS, PhD.
Top EHR complaints and how to solve them
June 23rd 2015It has been established that implementing electronic health records (EHR) has not been well received by physicians. Complaints of EHR costs and complications are among a laundry list of concerns physicians have voiced since the system’s mandated adoption. Ophthalmology Times asked three EHR experts to list the most common complaints they have heard physicians experience while addressing the implementation, and their advice on solving these issues.
OCT could assist in laser tissue bonding of corneal incisions
June 17th 2015A laser tissue bonding apparatus integrated with an optical coherence tomography (OCT) probe is a plausible instrument that allows for temperature-controlled laser bonding of incisions in the cornea, according to Israeli researchers. The OCT probe can provide real-time feedback of structural change of the corneal tissue, and indicate the progress and end point of the bonding.
New perspective posits amblyopia secondary to binocular problems
June 15th 2015Recent developments imply it may be time to change the current view of amblyopia. Laboratory findings show that the adult cortex is more adaptable than previously thought and that amblyopia may be secondary to binocular problems.
Trends in changing practice demographics, issues mirrored in AAO survey
June 15th 2015Among the trends from a membership survey conducted by the American Academy of Ophthalmology are an increase in part-time practice and greater diversity. However, many share similar concerns about upheavals in health care.
Best practices for injection protocols
June 15th 2015No doubt, my retina colleagues are way ahead of me in considering this issue. Reducing the frequency of injections by developing longer-lasting therapeutic agents and reducing the per-injection risk by careful scrutiny of evidence to determine the best practice when it comes to injection protocols are two possibilities.
How laser cataract surgery stacks up against conventional phaco
June 15th 2015Today’s laser cataract surgery is outperforming the early days of phacoemulsification and may outperform current phacoemulsification technology in the next few years, explained Yassine Daoud, MD, in a dialogue about the technology.
Evidence supports cataract surgery for IOP control in exfoliation syndrome
June 15th 2015Cataract surgery lowers IOP in eyes with exfoliation syndrome (XFS) or exfoliation glaucoma (XFG), and it might even change the natural history of glaucoma in eyes with XFS. However, it may also be appropriate to combine phacoemulsification with glaucoma surgery in certain patients with XFG.